Please try another search
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Name | Age | Since | Title |
---|---|---|---|
Robert J. Hombach | - | 2022 | Director |
Robert J. Hombach | 57 | 2022 | Independent Director |
David Frederic Melcher | 68 | 2022 | Independent Non-Executive Chairman |
David J. Albritton | 56 | 2022 | Independent Director |
Karen N. Prange | 59 | 2022 | Independent Director |
Christopher R. Reidy | 66 | 2022 | Director |
Devdatt Kurdikar | 54 | 2022 | President, CEO & Director |
Claire Pomeroy | 68 | 2022 | Independent Director |
Carrie L. Anderson | 54 | 2022 | Independent Director |
Milton M. Morris | 53 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review